MS and Demyelinating Disorders

The NeurologyLive® multiple sclerosis (MS) clinical focus page offers information, podcasts, videos, and news about the latest study and clinical trial findings, FDA actions, clinical guideline updates, and expert interviews related to the care and management of patients with MS, including relapsing MS and progressive MS, as well as related and demyelinating disorders such as neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease.

Latest News

FDA Action Update, January 2025: Approvals, Clearances, and Designations
FDA Action Update, January 2025: Approvals, Clearances, and Designations

February 4th 2025

Catch up on any of the neurology news headlines you may have missed over the course of January 2025, compiled all into one place by the NeurologyLive® team.

This Week on NeurologyLive® — February 3, 2024
This Week on NeurologyLive® — February 3, 2024

February 3rd 2025

Vivien Häußler, MD  (Credit: ResearchGate)
Real-World Study Highlights Immunotherapy Trends and Effectiveness in NMOSD and MOGAD

February 2nd 2025

Study Highlights Rare Case of Neuromyelitis Optica Spectrum Disorder Complicated by Posterior Reversible Encephalopathy Syndrome
Study Highlights Rare Case of Neuromyelitis Optica Spectrum Disorder Complicated by Posterior Reversible Encephalopathy Syndrome

February 1st 2025

Neal K. Shah  (Credit: CareYaya Health Technologies)
Taking on America’s Health Insurance Bureaucracy with AI

January 31st 2025

Latest CME Events & Activities

Individualizing Treatment for Patients with Generalized Myasthenia Gravis

View More

A New Era in NMOSD Treatment: Optimizing Therapeutic Transitions and Reducing Patient Burden

March 1, 2025

Register Now!

Patient, Provider & Caregiver Connection™: Reducing the Burden of Parkinson Disease Psychosis with Personalized Management Plans

View More

Clinical ShowCase™ in ALS: Addressing Diagnostic Delays, Evolving Therapies, and Multidisciplinary Care

View More

Burst Expert Illustrations & Commentary™: Visualizing the Role of FcRN in Neurological Disorders

View More

BURST Expert Illustrations and Commentaries™: Visualizing FcRn as a Therapeutic Target in Neurological Disease

View More

BURST Expert Illustrations and Commentaries™: Visualizing the Implications of FcRN-Targeted Therapies on Generalized Myasthenia Gravis

View More

Burst Expert Illustrations & Commentary™: Visualizing the Role of Subcutaneous Infusion as an Alternate Administration Route for Medical Interventions

View More

Clinical Consultations™: Navigating the Evolving Treatment Landscape in Generalized Myasthenia Gravis

View More

SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era

View More

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

View More

Expert Illustrations & Commentaries™: New Targets for Treatment in Cognitive Impairment in Schizophrenia – The Role of NMDA Receptors and Co-agonists

View More

BURST CME™ Part I: Understanding the Impact of Huntington’s Disease

View More

Burst CME™ Part II: The Evolving Treatment Landscape for Huntington Disease

View More

Carolina Neuromuscular Disease Summit

September 27, 2025

Register Now!

Evolving Perspectives in Alzheimer's Disease: Reaching an Earlier Diagnosis, Understanding Neuroinflammation, and Exploring Therapeutic Advances

View More

Clinical ShowCase: Developing a Personalized Treatment Plan for a Patient with Huntington’s Disease Associated Chorea

View More

SimulatEd™ From Discomfort to Relief: Acute Pain Management Essentials

View More

Medical Crossfire® - Optimizing Management for Patients With Generalized Myasthenia Gravis: Focus on Complement Inhibitors

View More

Medical Crossfire®: Integrating Real-World Data to Improve Outcomes for Patients With Multiple Sclerosis

View More

Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine

View More

Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings

View More

Evolving Perspectives in Alzheimer Disease : Reaching an Earlier Diagnosis, Understanding Neuroinflammation, and Exploring Therapeutic Advances

View More

Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine

View More

Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents

View More

Community Practice Connections™: Optimizing the Management of Tardive Dyskinesia—Addressing the Complexity of Care With Targeted Treatment

View More

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

View More

Patient, Provider, and Caregiver Connection™: Pediatric Myasthenia Gravis—Current Treatment and Emerging Concepts

View More

Mind Moments™: Optimizing Management for Patients with Generalized Myasthenia Gravis

View More

Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations

View More

© 2025 MJH Life Sciences

All rights reserved.